Who Owns Coram?

• Parent Company: CVS Health
• Ownership Type: Wholly owned
• Acquisition Year: 2006
• Company Type: Publicly Traded
• Stock Ticker: NYSE: CVS

• Founded: 1982
• Founders: Specialty pharmacy industry pioneers
• Acquired by CVS Health: 2006

• Founded: 1963
• Headquarters: Woonsocket, Rhode Island, USA
• Company Type: Publicly Traded
• Stock: NYSE: CVS
• Revenue: $402.1 billion (FY2025)
• Employees: Approximately 300,000

Visit CVS Health website

• Headquarters: Woonsocket, Rhode Island, USA
• Manufacturing / Operations: United States

Coram operates under CVS Health's comprehensive sustainability framework, implementing environmental initiatives focused on renewable energy investments, climate resilience, and sustainable healthcare practices. As CVS Health's specialty pharmacy and infusion services division, Coram participates in the company's broader environmental commitments while maintaining high standards for patient care and ethical pharmaceutical practices.

CVS Health Science-Based Net-Zero Commitment: Coram benefits from CVS Health's 2021 achievement as one of the first companies globally to have net-zero targets validated by the Science-Based Targets initiative's net-zero methodology. This commitment sets the company on a path to achieve net-zero emissions from direct operations and across the value chain by 2050, with systematic approaches to Scope 1, 2, and 3 emissions reduction.

Renewable Energy Portfolio Investments: CVS Health has completed seven renewable energy investments since 2022, with physical purchase power agreements representing more than 870,000 megawatt hours of clean renewable energy. By 2026, these investments will power approximately 3,000 CVS Health locations, including Coram facilities, supporting the company's carbon reduction goals and environmental stewardship commitments.

Electric Transportation and Logistics Innovation: CVS Health is pioneering sustainable transportation solutions that benefit Coram's distribution network. The company launched its first fully electric truck at the Patterson, California distribution center and electrified 100 trailer parking spots at the La Habra, California distribution center. Transportation refrigeration units have been upgraded to dual diesel and electric power, reducing emissions by five metric tons annually per unit.

Sustainable Supply Chain Engagement: Coram participates in CVS Health's supply chain sustainability initiatives, engaging suppliers to ensure they work toward science-based emissions reduction targets. Since 2018, the company has partnered with the United States Postal Service for prescription deliveries, utilizing monthly Carbon Accounting Service to monitor emissions associated with these deliveries.

Energy Efficiency and Operational Improvements: In 2024, CVS Health began using a new offsite data center powered by 100% renewable energy, retiring Solar Renewable Energy Credits. The company enrolled 37 CVS Pharmacy stores in Florida community solar programs through partnership with Florida Power & Light Company, demonstrating commitment to local renewable energy solutions.

Climate Resilience in Healthcare: Coram recognizes the connection between human and environmental health, implementing strategies to improve supply chain resilience against extreme weather events that could disrupt distribution of life-protecting medicines. The company focuses on serving communities most severely impacted by climate change, particularly those with socially vulnerable residents.

Sustainable Healthcare Delivery: Coram's specialty pharmacy and infusion services incorporate environmental considerations into healthcare delivery, including efficient routing for home care visits, sustainable medical waste management, and energy-efficient facility operations that maintain high patient care standards while reducing environmental impact.

Ethical Pharmaceutical Practices: As part of CVS Health, Coram maintains strict compliance with pharmaceutical industry regulations, ethical marketing practices, and patient privacy protections. The company operates under comprehensive quality assurance programs and industry-leading safety standards for sterile compounding and infusion therapy services.

Community Health and Environmental Justice: Coram's community engagement includes addressing health disparities that may be exacerbated by environmental factors, ensuring equitable access to specialty pharmacy and infusion services while contributing to community health resilience and environmental justice initiatives.

Innovation in Sustainable Healthcare Technology: Coram leverages CVS Health's investments in emerging technologies to improve both patient care and environmental performance, including digital health solutions that reduce the need for in-person visits and efficient inventory management systems that minimize waste and optimize resource utilization.

Coram has received recognition for industry-leading safety and quality standards in specialty pharmacy and infusion services, though much of its recognition is integrated within CVS Health's broader healthcare excellence awards. The brand's achievements focus on patient care quality, clinical excellence, and innovation in home infusion therapy and specialty pharmacy services.

Industry-Leading Safety and Quality Standards: Coram has been recognized for maintaining industry-leading safety and quality standards in specialty pharmacy and infusion services. The company's investment in its Pharmacy Quality Program, including an industry-leading microbiology laboratory, enables rigorous and frequent environmental testing across all Coram pharmacies, helping maintain sterile compounding clean rooms in a constant state of control.

Clinical Excellence Recognition: Coram's clinical team of nurses, dietitians, and pharmacists has been acknowledged for delivering high-quality infusion therapies, education, and support services to more than 50,000 patients each month. The team serves patients with complex conditions including immune deficiencies, Crohn's disease, and rheumatoid arthritis, demonstrating expertise in specialized infusion care.

Quality Infusion Care Outcomes: Coram has received recognition for quality infusion care that improves patient outcomes while lowering healthcare costs. With more than 35 years of experience, the company has been acknowledged for developing effective home-based infusion therapy models that reduce hospital readmissions and improve patient quality of life.

Sterile Compounding Excellence: The company's sterile compounding practices have been recognized as meeting or exceeding industry standards for safety and quality. Coram's microbiology laboratory and environmental testing protocols have been acknowledged as setting benchmarks for specialty pharmacy compounding operations.

Patient Education and Support Recognition: Coram's patient education programs and support services have been recognized for helping patients successfully manage complex infusion therapies at home. The company's comprehensive approach to patient care includes clinical monitoring, education, and ongoing support that improves treatment adherence and outcomes.

Integration Excellence with CVS Health: Coram's integration into CVS Health has been acknowledged as creating enhanced, comprehensive infusion and specialty pharmacy services that benefit from the resources and scale of one of America's largest healthcare companies.

Healthcare Innovation Recognition: Coram has been recognized for innovation in home-based healthcare delivery, particularly in developing effective models for alternate site care that reduce healthcare costs while maintaining high quality standards for patient care.

Professional Healthcare Partnerships: The company's collaborations with healthcare providers, hospitals, and health systems have been acknowledged for creating integrated care models that improve patient outcomes and reduce healthcare system costs.

Regulatory Compliance Recognition: Coram maintains recognition for regulatory compliance and adherence to healthcare industry standards, ensuring patient safety and quality care across all specialty pharmacy and infusion services.

Technology and Digital Health Integration: The company's adoption of digital health technologies and electronic health record connectivity has been recognized for improving specialty pharmacy efficiency and patient care coordination.

Coram has faced challenges related to service limitations and operational changes within the evolving healthcare landscape, though the brand has maintained a strong safety record and quality standards. The controversies primarily reflect broader challenges in the specialty pharmacy and infusion services industry, including market dynamics, regulatory changes, and healthcare cost management pressures.

2025 Infusion Services Reduction: In 2025, CVS Health announced significant changes to Coram's infusion services offerings, discontinuing acceptance of new patients for antibiotics, inotropic medications, total parenteral nutrition, and acute home infusion therapies programs. The company cited industry challenges and market dynamics as reasons for the reduction, though Coram continues to provide infusion services for specialty medications and enteral nutrition.

Service Access Concerns: The reduction in infusion services has raised concerns about patient access to certain types of home infusion therapy, particularly for patients requiring acute care services or specialized antibiotic treatments. Healthcare providers and patient advocates have expressed concerns about maintaining continuity of care for affected patients.

Healthcare Cost Pressures: Coram has faced challenges related to healthcare cost management and reimbursement pressures in the specialty pharmacy market. The evolving landscape of insurance coverage and reimbursement rates for infusion services has created operational challenges that have influenced service offerings and business decisions.

Regulatory Compliance Challenges: Like all specialty pharmacy providers, Coram operates in a highly regulated environment with complex compliance requirements for sterile compounding, controlled substances handling, and patient privacy protection. The company has had to continuously adapt to evolving regulatory requirements while maintaining service quality.

Market Competition Dynamics: The specialty pharmacy and infusion services market has become increasingly competitive, with new entrants and changing business models affecting traditional providers like Coram. Market dynamics have required strategic adjustments to maintain competitiveness and service viability.

Healthcare Industry Consolidation Impact: The consolidation of healthcare providers and pharmacy benefit managers has created challenges for independent specialty pharmacy operations, requiring adaptation to new business models and partnership arrangements within integrated healthcare systems.

Patient Care Transition Challenges: Changes in service offerings have required careful management of patient transitions to alternative providers, ensuring continuity of care and minimizing disruption to treatment plans for affected patients.

Supply Chain and Medication Access Issues: Coram has faced challenges related to medication shortages and supply chain disruptions that affect specialty pharmacy operations, requiring proactive management to ensure patient access to essential medications and infusion supplies.

Technology Integration Challenges: The integration of Coram services with CVS Health's broader technology platforms and electronic health record systems has presented operational challenges that have required significant investment and adaptation to ensure seamless service delivery.

Healthcare Policy and Reimbursement Changes: Changes in healthcare policy and reimbursement structures have created uncertainty for specialty pharmacy operations, requiring adaptation to new payment models and regulatory requirements that affect service delivery and business operations.